Financial results - BSD PHARMACEUTICALS SRL

Financial Summary - Bsd Pharmaceuticals Srl
Unique identification code: 37951269
Registration number: J37/525/2017
Nace: 4646
Sales - Ron
2.316.087
Net Profit - Ron
14.192
Employee
6
The most important financial indicators for the company Bsd Pharmaceuticals Srl - Unique Identification Number 37951269: sales in 2023 was 2.316.087 euro, registering a net profit of 14.192 euro and having an average number of 6 employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Bsd Pharmaceuticals Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - 0 87 391 22.378 1.216 516.555 2.316.087
Total Income - EUR - - - 0 103 631 22.379 1.216 516.555 2.319.162
Total Expenses - EUR - - - 26.234 77.576 70.423 85.052 92.525 548.753 2.296.612
Gross Profit/Loss - EUR - - - -26.234 -77.473 -69.792 -62.673 -91.309 -32.198 22.551
Net Profit/Loss - EUR - - - -26.234 -77.474 -69.798 -62.880 -91.321 -36.079 14.192
Employees - - - 5 7 5 7 6 6 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 349.7%, from 516.555 euro in the year 2022, to 2.316.087 euro in 2023. The Net Profit increased by 14.192 euro, from 0 euro in 2022, to 14.192 in the last year.

Check the financial reports for the company - Bsd Pharmaceuticals Srl

Rating financiar

Financial Rating -
Bsd Pharmaceuticals Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Bsd Pharmaceuticals Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bsd Pharmaceuticals Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Bsd Pharmaceuticals Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bsd Pharmaceuticals Srl - CUI 37951269

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - 4.111 21.422 15.018 10.090 2.958 1.621 4.227
Current Assets - - - 7.446 11.835 16.838 23.976 9.780 100.008 74.525
Inventories - - - 2.612 2.575 3.664 3.485 4.699 76.154 2.093
Receivables - - - 2.542 8.969 12.536 14.931 3.206 16.739 70.124
Cash - - - 2.292 292 639 5.560 1.876 7.115 2.309
Shareholders Funds - - - -26.191 -103.184 -170.984 -230.623 -316.830 -353.892 -338.627
Social Capital - - - 44 43 42 41 40 41 40
Debts - - - 37.747 136.441 202.840 264.689 329.568 455.520 417.379
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 74.525 euro in 2023 which includes Inventories of 2.093 euro, Receivables of 70.124 euro and cash availability of 2.309 euro.
The company's Equity was valued at -338.627 euro, while total Liabilities amounted to 417.379 euro. Equity increased by 14.192 euro, from -353.892 euro in 2022, to -338.627 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Bsd Pharmaceuticals Srl

Comments - Bsd Pharmaceuticals Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.